Fulgent Genetics, Inc. FLGT Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s net change in cash?
- Fulgent Genetics, Inc. (FLGT) reported net change in cash of -$26.79M in Q1 2026.
- How has Fulgent Genetics, Inc.'s net change in cash changed year-over-year?
- Fulgent Genetics, Inc.'s net change in cash decreased by 320.8% year-over-year, from $12.14M to -$26.79M.
- What is the long-term trend for Fulgent Genetics, Inc.'s net change in cash?
- Over 2 years (2022 to 2025), Fulgent Genetics, Inc.'s net change in cash has grown at a -75.9% compound annual growth rate (CAGR), from -$85.39M to -$4.95M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.